信号转导
药理学
化学
细胞生物学
计算生物学
生物
标识
DOI:10.1016/j.tibs.2024.09.002
摘要
Targeted protein degradation is an innovative therapeutic modality for the degradation of disease-causing proteins. In a recent report combining high-throughput screening of small-molecule compounds and biochemical analyses, Mori et al. identified certain inhibitors of cellular pathways, such as PARylation and proteostatic pathways, which enhance proteolysis-targeting chimera (PROTAC)-induced protein degradation.
科研通智能强力驱动
Strongly Powered by AbleSci AI